Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Robert Perneczky
Based on 7 articles published since 2008
||||
Expertise Level
The expertise of Robert Perneczky ranks in the
  • Top 7.4%
  • ... of 70,275 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    Technical University of Munich      
2015
  • Department of Neurology, Kiel University, Kiel, Germany · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Department of Radiology, Bonn University, Bonn, Germany. · Neuroepidemiology and Ageing Research Unit, Imperial College of Science, Technology and Medicine, London, United Kingdom Cognitive Impairment and Dementia Services, West London Mental Health NHS Trust, London, United Kingdom Department of Psychiatry, TU Munich, Munich, Germany. · Department of Psychiatry, TU Munich, Munich, Germany. · Department of Neurology, Kiel University, Kiel, Germany. · Department of Psychiatry, Kiel University, Kiel, Germany; and LVR Clinic Cologne, Academic Teaching Hospital, University of Cologne, Cologne, Germany. · Pubmed 26383147
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
2011
  • Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Pubmed 21310235
2008
  • Department of Psychiatry and Psychotherapy, Technische Universität Munchen, Munich, Germany. · Pubmed 18984958
Probable:    Ludwig-Maximilians-Universitat      
2015
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
2011
  • Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Pubmed 21310235
2008
  • Department of Psychiatry and Psychotherapy, Technische Universität Munchen, Munich, Germany. · Pubmed 18984958
Probable:    Imperial College London      
2015
  • Department of Neurology, Kiel University, Kiel, Germany · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Department of Radiology, Bonn University, Bonn, Germany. · Neuroepidemiology and Ageing Research Unit, Imperial College of Science, Technology and Medicine, London, United Kingdom Cognitive Impairment and Dementia Services, West London Mental Health NHS Trust, London, United Kingdom Department of Psychiatry, TU Munich, Munich, Germany. · Department of Psychiatry, TU Munich, Munich, Germany. · Department of Neurology, Kiel University, Kiel, Germany. · Department of Psychiatry, Kiel University, Kiel, Germany; and LVR Clinic Cologne, Academic Teaching Hospital, University of Cologne, Cologne, Germany. · Pubmed 26383147
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Robert Perneczky in 2008-2019 about Parkinson Disease:

  • Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits. 2015
  • The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. 2015
  • Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease. 2015
  • Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. 2013
  • Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. 2011
  • Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. 2009
  • Activities of daily living, cerebral glucose metabolism, and cognitive reserve in Lewy body and Parkinson's disease. 2008
Show List of Full Article Records
Google Searches

Learn more about Robert Perneczky using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Technical University of Munich
Ludwig-Maximilians-Universitat
Imperial College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Technical University of Munich
2015
  • Department of Neurology, Kiel University, Kiel, Germany · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Department of Radiology, Bonn University, Bonn, Germany. · Neuroepidemiology and Ageing Research Unit, Imperial College of Science, Technology and Medicine, London, United Kingdom Cognitive Impairment and Dementia Services, West London Mental Health NHS Trust, London, United Kingdom Department of Psychiatry, TU Munich, Munich, Germany. · Department of Psychiatry, TU Munich, Munich, Germany. · Department of Neurology, Kiel University, Kiel, Germany. · Department of Psychiatry, Kiel University, Kiel, Germany; and LVR Clinic Cologne, Academic Teaching Hospital, University of Cologne, Cologne, Germany. · Pubmed 26383147
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
2011
  • Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Pubmed 21310235
2008
  • Department of Psychiatry and Psychotherapy, Technische Universität Munchen, Munich, Germany. · Pubmed 18984958
Ludwig-Maximilians-Universitat
2015
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
2011
  • Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Pubmed 21310235
2008
  • Department of Psychiatry and Psychotherapy, Technische Universität Munchen, Munich, Germany. · Pubmed 18984958
Imperial College London
2015
  • Department of Neurology, Kiel University, Kiel, Germany · Department of Nuclear Medicine, University of Cologne, Cologne, Germany. · Department of Radiology, Bonn University, Bonn, Germany. · Neuroepidemiology and Ageing Research Unit, Imperial College of Science, Technology and Medicine, London, United Kingdom Cognitive Impairment and Dementia Services, West London Mental Health NHS Trust, London, United Kingdom Department of Psychiatry, TU Munich, Munich, Germany. · Department of Psychiatry, TU Munich, Munich, Germany. · Department of Neurology, Kiel University, Kiel, Germany. · Department of Psychiatry, Kiel University, Kiel, Germany; and LVR Clinic Cologne, Academic Teaching Hospital, University of Cologne, Cologne, Germany. · Pubmed 26383147
  • Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: · Department of Neurology, Oslo University Hospital, Oslo, Norway. · Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK. · Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Max Planck Institute for Human Development, Berlin, Germany. · Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. · Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy. · Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy. · Department of Neurology, Linköping University, Linköping, Sweden. · Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany. · Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. · Department of Neurology, University of Ulm, Ulm, Germany. · The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. · School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. · Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. · Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. · Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy. · Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany. · Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK. · Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy. · Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands. · Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, UK. · AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France. · Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA. · Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK. · Pubmed 25936935
  • Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Department of Biochemistry, Adolf-Butenandt-Institut, Ludwig-Maximilians Universität München, Munich, Germany. · German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. · Paracelsus Elena Klinik, Kassel, Germany. · Neurochirurgische Klinik, Georg August Universität Göttingen, Göttingen, Germany. · Genomics and Disease Group, Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF) and Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, Barcelona, Spain. · Institut für Neuropathologie, Ludwig-Maximillians Universität München, Munich, Germany. · Psychiatrische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Psychiatrische Universitätsklinik, Albert Ludwigs Universität, Freiburg, Germany. · Institut für Humangenetik, Technische Universität München, Munich, Germany. · Department of Neurology, Medical University of Vienna, Vienna, Austria. · Neurologische Klinik, Wilhelminenspital, Vienna, Austria. · Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary. · Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain. · Department of Neurology, Clinica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. · CIBERNED, Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Spain. · Institut für Epidemiologie II, Helmholtz Zentrum München, Munich, Germany. · Institut für Genetische Epidemiologie, Helmholtz Zentrum München, Munich, Germany. · Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Pubmed 25604855
2013
  • Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Paracelsus-Elena-Klinik, Kassel, Germany ; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany. · Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany. · Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany. · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France. · Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France ; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France. · Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. · Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany ; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom ; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom. · Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany. · Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany ; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany ; Institut für Humangenetik, Technische Universität München, Munich, Germany ; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany ; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America. · Pubmed 24386122
Universita degli Studi di Bari Aldo Moro
2009
  • Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy. · Pubmed 19705471
Yearly article counts 000030101011
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.